Close
ACHEMA MIDDLE EAST 2026

Biosimulation Market Size and Growth Projections: 2025–2030

In the rapidly evolving landscape of drug discovery and development, biosimulation has emerged as an indispensable tool that stands at the intersection of computational...

The Future of Clinical Trial Data in Decentralisation Models

The landscape of clinical research is undergoing a seismic shift, powered by technological advancement, shifting patient expectations, and a worldwide drive for more effective...

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

GSK plc announced it has entered into agreements with Hengrui Pharma to develop up to 12 innovative medicines, adding significant new growth opportunities to...

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

Aptar Pharma, a global leader in drug delivery and active material science solutions and services, announced its acquisition of the clinical trial materials manufacturing...

FDA Accepts BLA for Recommended Biosimilar to Simponi

Bio-Thera Solutions announced that the FDA has accepted its Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi® (golimumab).  The FDA goal...

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

Merck to acquire Verona Pharma, a UK-based pharmaceutical company in a $10 billion acquisition, adding the promising respiratory drug Ohtuvayre into its pipeline as...

Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

The landscape of medicine is ever-changing, and progress is obvious in developing treatments for ultra-rare disorders. Ultra-rare disorders are characterised as infrequently recognised conditions...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...